Cytological evaluation and molecular human papillomavirus test of cervical scrapings from women treated for condyloma?

Gynecologic and Obstetric Investigation

Volumn 42, Issue 2, 1996, Pages 128-132

  Zehbe, Ingeborg ^a   Strand, Anders ^b   Ling Chua, Keng ^c   Wilander, Erik ^a  

^a Departments of Pathology   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Huddinge Sjukhus   (Italy)

Author keywords

Cervical intraepithelial neoplasia; Cervical scraping; Cytology; Human papillomavirus DNA; Polymerase chain reaction

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SCREENING; CONDYLOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SWEDEN; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 0029813965     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291921     Document Type: Article

References (23)

1. Pcttersson F, Bjorkholm E, Naslund 1: Evaluation of screening for cervical cancer in Sweden: Trends in incidence and mortality 1958-1980. Int J Epidemiol 1985; 14:521-527.
2. Gustafsson L, Adami HO: Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. Br J Cancer 1990:61:903-908.
3. Bergstrom R, Adami HO. Gustafsson L. Pon-tén J, Sparén P: Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst 1993:85: 1050-1057.
4. Rylandcr E: Cervical cancer in women belonging to a cytologically screened population. Acta Obstet Gynecol Scand 1976:55:361-366.
5. Durst M. Gissmann L, Ikcnbcrg H, zur Hausen H: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983:80:3812-3814.
6. Crum CP, Ikenberg H, Gissmann L: Human papillomavirus 16 in early cervical neoplasia. N Engl J Med 1984:310: 880-883.
7. Crum CP. Nuovo G. Friedman D. Silvcrstein SJ: in situ hybridization analysis of human papillomavirus 16 DNA sequences in early cervical neoplasia. Am J Pathol 1986; 123:174— 182.
8. Lorincz, AT, Reid R. Jenson AB. Greenberg MD. Lancaster W, Jurman RJ: Human papillomavirus infection of the cervix: Relative risk association of 15 common anogenital types. Obstet Gynecol 1992;79:328-337.
9. De Villiers EM, Gissmann L, zur Hausen H: Molecular cloning of viral DNA from genital warts. J Virol 1981:40:932-935.
10. Gissmann L. Diehl V. Schultz-Coulon HJ. zur Hausen H: Molecular cloning and characterization of HPV DNA derived from laryngeal papilloma. J Virol 1982:44:393-400.
11. Reid R. Greenberg MD. Lorincz AT. Bennett Jenson A. Lavcrty CR. Husain M. Daoud Y. Zado B. White T. Cantor D. Goldrath M: Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 1991:164:1461-1471.
12. Koutsky LA, Holmes KK, Critchlow CW. Stevens CE, Paavoncn J, Beckmann AM. Dc Rouen TA, Galloway D, Vernon D. Kiviat NB: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327: 1272—1278.
13. Cox JT, Schiffman MH, Winzclbcrg AJ. Patterson MS: An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol 1992:119:389-399.
14. Meijer CJLM, van den Brüle AJC, Snijders PJF, Helmerhorst T, Kenemans P, Walboom-ers JMM: Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: Possible implications for cervical cancer screening; in Munoz N, Bosch FX. Shah KV, Meheus A (eds): The Epidemiology of Human Papillomavirus and Cervical Cancer. Lyon, IARC, 1992, pp271-281.
15. Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD. Emery VC, Walker PG: Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer 1992:67:602-605.
16. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST, Guillebaud J: Human papillomavirus testing in primary cervical screening. Lancet 1995; 345:1533-1536.
17. Cox JT, Lorincz AT, Schiffman MH: HPV testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of ASCUS. Am J Obstet Gynecol 1995; 172:946-954.
18. Chua KL, Hjerpe A: Polymerase chain reaction (PCR) analysis of human papillomavirus (HPV) in archival Pap smears. Anal Quant Cytol Histol 1995;17:221-229.
19. Zehbe I, Rylander E, Edlund K, Wadell G, Wilander E: Detection of human papillomavirus in cervical intra-epithelial neoplasia by using in situ hybridisation and various polymerase chain reaction techniques. Virchows Arch, in press.
20. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354.
21. De Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF: The use of the general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-1062.
22. Erlich HA, Gelfand D, Sninsky JJ: Recent advances in the polymerase chain reaction. Science 1991;252:1643-1656.
23. Evander M, Edlund K, Boden E, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Wadell G: Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papi., lomavirus infection in young Swedish women. J Clin Microbiol 1992:30:987-992.